Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Prime Movers Lab
BioCentury | Dec 12, 2023
Deals
Dec. 11 Quick Takes: BMS paying $800M up front for SystImmune’s bispecific ADC
Plus: Pain, hearing loss company Hoba raises €23M and more from Novartis, Cogent and Zafrens
BioCentury | Dec 16, 2022
Finance
Dec. 15 Quick Takes: Enlaza debuts with $61M, covalent targeting biologics platform
Plus: MinervaX taking strep vaccine to Phase II and updates from AbbVie, Prothena, Astria, Guardant and more
BioCentury | Aug 17, 2021
Deals
Aug. 16 Quick Takes: Change of heart preceded Sanofi’s buyout of Translate Bio
Plus: $772M IPO for Sino Biological, COVID boosters, Sesen woes, Rigel, Tyvyt, lebrikizumab and more
BioCentury | May 7, 2021
Deals
May 7 Quick Takes: SpringWorks makes bet on TEAD portfolio; plus CRISPR-Nkarta, Valneva and more
BioCentury | Feb 17, 2021
Management Tracks
Athersys chair Gil Van Bokkelen steps down; plus Strongbridge, Medical Alley Association, Freeline, AlzeCure, Egetis, Arena and Prime Movers
Regenerative medicine company Athersys Inc. (NASDAQ:ATHX) said Chairman and CEO Gil Van Bokkelen has stepped down. While the company searches for a successor, President and COO William Lehmann will be
BioCentury | Nov 24, 2020
Product Development
Nov. 24 Quick Takes: Elevian raises $15M; plus AZ-Ionis, Genmab, Moderna and Novartis
Anti-aging play Elevian raises $15M equity roundElevian Inc. raised $15 million in an equity financing led by Prime Movers Lab. Also participating were Bold Capital Partners, For Good Ventures, Kizoo
Items per page:
1 - 6 of 6